eli lilly phase 3 trial retatrutide Retatrutide, an experimental drug currently in clinical trials, is nicknamed the Godzilla of weight-loss jabs because of its potential superior efficacy. Developed by Lilly, is a triple hormone Eli Lilly and Company's Retatrutide

During the initial weeks of treatment, it is reasonable to reduce the intensity of physical activity and prioritise adequate sleep

Adjusting Frequency During the Titration Phase Although the end goal is weekly injections, most patients begin with a lower dose and gradually increase over several weeks

Fat is more than storage

But what is actually also important is that in terms of perception, it may actually give wrong perception to patients who actually buy this medication. The claim that the patches may help to improve glucagon-like peptide-1 (GLP-1) production in the body is not scientifically proven, said Dr Khoo, referring to the naturally occurring gut hormone that has sparked widespread obsession for its role in weight loss

Over time, this can lead to real weight reduction